牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

毕得医药（688073）

6.2

综合诊断：6.2分打败了81%的股票！

卖出
减持
中性
增持
买入

短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
中期趋势：
正处于反弹阶段。
长期趋势：
已有173家主力机构披露2025-06-30报告期持股数据，持仓量总计2439.11万股，占流通A股56.42%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

5.9分

7.2分

5.5分

4.8分

6.6分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：5.9技术面打败了26%的股票技术面评分前10的股票

近期的平均成本为69.22元。空头行情中，目前正处于反弹阶段，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为69.22元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"69.22","date":1768124182,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势接近大盘，跑输行业平均水平。

[{"date":"2026.01.12","stock":"-0.12","trade":"3.34","ind":"1.09"},{"date":"2026.01.09","stock":"6.46","trade":"3.44","ind":"0.92"},{"date":"2026.01.08","stock":"-3.61","trade":"1.92","ind":"-0.07"},{"date":"2026.01.07","stock":"1.47","trade":"1.38","ind":"0.05"},{"date":"2026.01.06","stock":"2.12","trade":"1.06","ind":"1.50"},{"date":"2026.01.05","stock":"6.83","trade":"5.59","ind":"1.38"},{"date":"2025.12.31","stock":"0.66","trade":"0.02","ind":"0.09"},{"date":"2025.12.30","stock":"-5.88","trade":"-0.85","ind":"-0.00"},{"date":"2025.12.29","stock":"-1.44","trade":"-0.28","ind":"0.04"},{"date":"2025.12.26","stock":"-2.16","trade":"-0.85","ind":"0.10"},{"date":"2025.12.25","stock":"2.33","trade":"0.98","ind":"0.47"},{"date":"2025.12.24","stock":"0.42","trade":"0.53","ind":"0.53"},{"date":"2025.12.23","stock":"-0.05","trade":"-0.51","ind":"0.07"},{"date":"2025.12.22","stock":"0.87","trade":"-0.40","ind":"0.69"},{"date":"2025.12.19","stock":"-0.29","trade":"1.30","ind":"0.36"},{"date":"2025.12.18","stock":"-1.57","trade":"1.23","ind":"0.16"},{"date":"2025.12.17","stock":"1.29","trade":"1.60","ind":"1.19"},{"date":"2025.12.16","stock":"-1.93","trade":"-1.76","ind":"-1.11"},{"date":"2025.12.15","stock":"-1.97","trade":"-1.19","ind":"-0.55"},{"date":"2025.12.12","stock":"0.73","trade":"0.81","ind":"0.41"},{"date":"2025.12.11","stock":"-1.35","trade":"-0.91","ind":"-0.70"}]

毕得医药,上证指数,医疗服务指数

压力支撑

该股压力位为68.80元，支撑位为67.15元。

[{"text":"\u538b\u529b\u4f4d","value":"68.80","date":1768147200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"67.15","date":1768147200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：7.2资金面打败了94%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体无进出。

更新时间：01月12日 18:34

机构今日流向(万元)	-1272.26	机构5日流向(万元)	1188.50
机构10日流向(万元)	4198.90	机构20日流向(万元)	4895.51

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加3.88万股，其中基金净减仓3家，主力净增仓64家，请投资者中长期谨慎为宜。

截止2025-06-30，共173家主力机构（基金169家，一般法人3家，社保基金1家），持仓量总计2439.11万股，占流通A股56.42%
其中，基金持仓与2024-12-31相比：
增仓：18家，增持 196.27万股
减仓：21家，减持 107.63万股
新出现在主力名单中：121家，持有1143.89万股
从主力名单中消失：57家，原持有1221.15万股

消息面诊股

诊断结果：5.5消息面打败了86%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	关联交易	2026-01-06
一般消息	股东大会	临时股东大会	2025-11-25
一般消息	分红转增	不分配不转增	2025-08-22
一般消息	高管变动	公司内部工作调整	2025-08-21
一般消息	高管变动	公司内部工作调整	2025-08-15
一般消息	高管变动	取消监事会	2025-07-31
利好	分红转增	10派9元(含税)	2025-04-24
一般消息	重大事项	关联交易	2025-04-15
一般消息	高管变动	个人原因	2025-03-11
利空	股票增发	停止实施	2025-01-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	0条	1条

行业面诊股

诊断结果：4.8行业面打败了63%的股票医疗服务行业最新资金流向

近10日来该行业走势明显向上，明显跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，明显跑赢大盘。

[{"date":"2026.01.12","price":"1.09","value":"3.34"},{"date":"2026.01.09","price":"0.92","value":"3.44"},{"date":"2026.01.08","price":"-0.07","value":"1.92"},{"date":"2026.01.07","price":"0.05","value":"1.38"},{"date":"2026.01.06","price":"1.50","value":"1.06"},{"date":"2026.01.05","price":"1.38","value":"5.59"},{"date":"2025.12.31","price":"0.09","value":"0.02"},{"date":"2025.12.30","price":"-0.00","value":"-0.85"},{"date":"2025.12.29","price":"0.04","value":"-0.28"},{"date":"2025.12.26","price":"0.10","value":"-0.85"},{"date":"2025.12.25","price":"0.47","value":"0.98"},{"date":"2025.12.24","price":"0.53","value":"0.53"},{"date":"2025.12.23","price":"0.07","value":"-0.51"},{"date":"2025.12.22","price":"0.69","value":"-0.40"},{"date":"2025.12.19","price":"0.36","value":"1.30"},{"date":"2025.12.18","price":"0.16","value":"1.23"},{"date":"2025.12.17","price":"1.19","value":"1.60"},{"date":"2025.12.16","price":"-1.11","value":"-1.76"},{"date":"2025.12.15","price":"-0.55","value":"-1.19"},{"date":"2025.12.12","price":"0.41","value":"0.81"},{"date":"2025.12.11","price":"-0.70","value":"-0.91"}]

上证指数,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	三博脑科	84.94%	39.16%	6.7分
2	创新医疗	75.72%	56.34%	6.3分
3	迪安诊断	73.39%	52.13%	6.1分
4	泓博医药	55.80%	47.58%	7.1分
5	成都先导	52.83%	41.55%	7.0分
6	益诺思	46.82%	34.67%	6.8分
7	美年健康	39.26%	23.44%	6.5分
8	-	34.33%	17.18%	分
9	盈康生命	33.33%	16.70%	6.7分
10	金域医学	32.11%	25.65%	6.4分
11	普蕊斯	29.85%	8.96%	6.7分
12	昭衍新药	29.30%	4.86%	6.1分
13	睿智医药	28.41%	24.73%	6.8分
14	美迪西	26.36%	16.61%	6.5分
15	诚达药业	25.06%	15.00%	5.9分
16	华大基因	24.29%	15.30%	6.2分
17	华康洁净	22.83%	-2.04%	4.6分
18	泰格医药	21.53%	1.03%	6.3分
19	诺禾致源	19.02%	13.07%	6.7分
20	药石科技	18.82%	13.63%	6.0分
21	贝瑞基因	18.38%	8.77%	6.3分
22	南模生物	17.93%	7.65%	6.2分
23	博济医药	15.56%	5.69%	5.8分
24	兰卫医学	14.01%	8.53%	6.1分
25	和元生物	13.87%	10.48%	6.0分
26	药康生物	13.84%	8.71%	6.5分
27	阳光诺和	12.65%	19.09%	7.0分
28	百诚医药	12.09%	3.65%	5.7分
29	国际医学	11.79%	8.47%	5.9分
30	凯莱英	11.75%	8.98%	6.3分
31	皓元医药	11.74%	10.29%	6.6分
32	诺思格	11.42%	3.16%	5.5分
33	金凯生科	9.43%	4.62%	6.0分
34	康龙化成	8.61%	4.82%	6.5分
35	博腾股份	8.43%	5.78%	6.0分
36	普瑞眼科	7.71%	3.95%	5.8分
37	万邦医药	7.28%	5.36%	5.4分
38	何氏眼科	7.04%	3.63%	5.9分
39	百奥赛图	6.51%	24.76%	7.0分
40	九洲药业	6.46%	4.57%	6.2分
41	药明康德	5.65%	4.35%	6.6分
42	爱尔眼科	5.63%	4.03%	6.2分
43	澳洋健康	5.03%	2.70%	5.0分
44	通策医疗	4.75%	2.92%	5.9分
45	奥浦迈	4.16%	2.95%	5.8分
46	光正眼科	4.01%	4.75%	5.9分
47	海特生物	3.65%	2.40%	4.6分
48	毕得医药	3.39%	6.21%	6.2分
49	新里程	2.71%	4.13%	6.0分
50	华厦眼科	1.76%	3.97%	5.8分
51	皓宸医疗	0.64%	3.61%	5.5分
52	百花医药	-2.96%	-17.82%	5.0分
53	*ST生物	-5.33%	-3.40%	4.2分
54	ST中珠	-5.80%	3.17%	5.2分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.6基本面打败了78%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：中（97.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/102 ， 18/102。

[{"date":"2025-09-30","value":"5.94","vol":"3.33"},{"date":"2025-06-30","value":"3.69","vol":"2.29"},{"date":"2025-03-31","value":"1.51","vol":"0.92"},{"date":"2024-12-31","value":"5.70","vol":"-0.06"},{"date":"2024-09-30","value":"4.10","vol":"3.18"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	5.94	3.69	1.51	5.70	4.10
行业(%)	3.33	2.29	0.92	-0.06	3.18

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"44.45","vol":"36.63"},{"date":"2025-06-30","value":"44.25","vol":"36.78"},{"date":"2025-03-31","value":"44.34","vol":"34.67"},{"date":"2024-12-31","value":"41.33","vol":"35.58"},{"date":"2024-09-30","value":"41.17","vol":"36.89"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	44.45	44.25	44.34	41.33	41.17
行业(%)	36.63	36.78	34.67	35.58	36.89

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/102 ， 22/102。

[{"date":"2025-09-30","value":"20.67","vol":"3.55"},{"date":"2025-06-30","value":"17.91","vol":"3.34"},{"date":"2025-03-31","value":"12.83","vol":"-0.08"},{"date":"2024-12-31","value":"0.93","vol":"-0.03"},{"date":"2024-09-30","value":"0.79","vol":"0.85"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	20.67	17.91	12.83	0.93	0.79
行业(%)	3.55	3.34	-0.08	-0.03	0.85

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"42.79","vol":"19.50"},{"date":"2025-06-30","value":"41.60","vol":"-66.44"},{"date":"2025-03-31","value":"17.71","vol":"-25.93"},{"date":"2024-12-31","value":"7.17","vol":"-92.66"},{"date":"2024-09-30","value":"-26.05","vol":"-158.04"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	42.79	41.60	17.71	7.17	-26.05
行业(%)	19.50	-66.44	-25.93	-92.66	-158.04

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 14/102 ， 51/102。

[{"date":"2025-09-30","value":"0.39","vol":"0.31"},{"date":"2025-06-30","value":"0.25","vol":"0.20"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.46","vol":"0.41"},{"date":"2024-09-30","value":"0.34","vol":"0.31"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.39	0.25	0.12	0.46	0.34
行业(次)	0.31	0.20	0.10	0.41	0.31

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.65","vol":"11.19"},{"date":"2025-06-30","value":"0.43","vol":"7.29"},{"date":"2025-03-31","value":"0.21","vol":"3.76"},{"date":"2024-12-31","value":"0.89","vol":"16.08"},{"date":"2024-09-30","value":"0.68","vol":"13.98"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.65	0.43	0.21	0.89	0.68
行业(次)	11.19	7.29	3.76	16.08	13.98

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-2.10","vol":"16.25"},{"date":"2025-06-30","value":"2.72","vol":"15.87"},{"date":"2025-03-31","value":"2.39","vol":"-1.69"},{"date":"2024-12-31","value":"19.87","vol":"22.45"},{"date":"2024-09-30","value":"3.89","vol":"12.75"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-2.10	2.72	2.39	19.87	3.89
行业	16.25	15.87	-1.69	22.45	12.75

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.29","vol":"0.93"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.02","vol":"1.29"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.29	-	2.02	-
行业	0.01	0.93	0.00	1.29	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 41/102 ， 37/102。

[{"date":"2025-09-30","value":"4.56","vol":"3.76"},{"date":"2025-06-30","value":"4.31","vol":"3.66"},{"date":"2025-03-31","value":"2.88","vol":"3.84"},{"date":"2024-12-31","value":"6.39","vol":"3.66"},{"date":"2024-09-30","value":"6.84","vol":"4.04"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	4.56	4.31	2.88	6.39	6.84
行业	3.76	3.66	3.84	3.66	4.04

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.73","vol":"3.03"},{"date":"2025-06-30","value":"2.69","vol":"2.95"},{"date":"2025-03-31","value":"1.48","vol":"3.12"},{"date":"2024-12-31","value":"4.12","vol":"2.98"},{"date":"2024-09-30","value":"4.49","vol":"3.32"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	2.73	2.69	1.48	4.12	4.49
行业	3.03	2.95	3.12	2.98	3.32

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/102 ， 36/102。

[{"date":"2025-09-30","value":"21.87","vol":"32.25"},{"date":"2025-06-30","value":"22.98","vol":"33.24"},{"date":"2025-03-31","value":"23.82","vol":"32.24"},{"date":"2024-12-31","value":"16.17","vol":"32.93"},{"date":"2024-09-30","value":"15.06","vol":"30.45"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	21.87	22.98	23.82	16.17	15.06
行业(%)	32.25	33.24	32.24	32.93	30.45

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.28","vol":"0.92"},{"date":"2025-06-30","value":"0.30","vol":"0.96"},{"date":"2025-03-31","value":"0.31","vol":"0.98"},{"date":"2024-12-31","value":"0.19","vol":"1.03"},{"date":"2024-09-30","value":"0.18","vol":"0.83"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.28	0.30	0.31	0.19	0.18
行业(%)	0.92	0.96	0.98	1.03	0.83

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
兴业证券	2025-11-18	增持
太平洋	2025-10-30	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"0.98","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.46","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.10","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.17","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.53","blueLineValue":"1.68","type":"YC"}]

[毕得医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]